Skip to content

Clinical study of tranexamic acid drug-infiltrated threads for the treatment of melasma

Clinical study of tranexamic acid drug-infiltrated threads for the treatment of melasma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2022000039
Enrollment
Unknown
Registered
2022-06-27
Start date
2022-06-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

melasma

Interventions

Simple buried wire group:Simply buried wire
Tranexamic acid line implant group:Tranexamic acid line implantation
Tranexamic acid injection group:Tranexamic acid injection

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Age 18 to 60 years old, female; (2) Those who have not received acupuncture point burial thread treatment before; (3) Meet the diagnostic criteria for melasma; (4) The clinical stage is a stable stage; (5) Each patient understands the purpose and method of this study before the trial, and voluntarily participates in it, and signs the informed consent of the trial Book.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) Patients who are allergic to the use of drugs in this study; (3) Patients with inflammatory or infectious skin diseases at the treatment site; (4) Patients with severe endocrine, gynecological, cardiovascular and cerebrovascular diseases, abnormal coagulation function, abnormal liver and kidney function and tumors; (5) Those who have received laser treatment, oral or topical freckle removal drugs in the past 1 month; (6) If the sunscreen cannot be achieved as required during the treatment.

Design outcomes

Primary

MeasureTime frame
Melasma area severity index;Patient satisfaction evaluation;

Countries

China

Contacts

Public ContactZhou Shuang-lin
13911055110@163.com13911055110

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026